Meloxicam for oral administration

US6869948B1 · kind B1 · utility

Assignee

• BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

• Thomas Bock · Mont de Marsan, FR
• Paul Saegmueller · Bergatreute, DE
• Peter Sieger · Mittelbiberach, DE
• Dietrich Tuerck · Ulm, DE

Key dates

• Filing date: Mar 26, 1999
• Grant date: Mar 22, 2005
• Expiry date: Sep 30, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/4866
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates in its first aspect to a rapidly decomposing tablet for pain therapy containing meloxicam [4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide] in the form of a salt with an inorganic or organic base providing rapid absorption of the active substance, the process of its preparation by direct tabletting, and furthermore relates in a second aspect to the crystalline meloxicam meglumin salt mono- and dihydrate and the preparation thereof.